Cancer Incidence and Mortality for Montgomery County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 333.0 513.0 487.7-539.4 159.4 539.5 501.4-579.7 173.6 500.4 466.0-536.8 112.6 164.6 150.8-179.4 58.4 194.0 171.8-218.4 54.2 143.4 126.0-162.8
Oral cavity and pharynx 8.6 14.1 10.0-19.3 6.2 21.8 14.6-31.6 2.4 6.9 3.4-12.8 2.8 4.4 2.4-7.6 2.0 6.7 3.1-12.7 0.8 2.4 0.6-6.6
Esophagus 2.6 4.3 2.2-7.5 1.8 6.2 2.8-12.1 0.8 2.6 0.6-7.2 3.2 5.5 3.1-9.1 2.4 8.4 4.3-15.0 0.8 3.0 0.8-7.8
Stomach 3.6 5.6 3.3-9.1 2.2 7.4 3.6-13.7 1.4 4.0 1.5-8.9 1.8 2.6 1.1-5.2 0.6 2.2 0.5-6.7 1.2 2.8 0.9-6.9
Colorectal 31.2 49.3 41.6-58.2 15.0 52.6 41.0-66.5 16.2 47.1 36.8-59.6 9.6 14.3 10.4-19.2 4.6 15.6 9.8-23.7 5.0 12.9 8.1-19.9
Colon excluding rectum 22.8 35.4 29.0-43.0 9.4 33.4 24.3-44.8 13.4 37.5 28.5-48.6 8.2 12.0 8.5-16.6 3.8 12.6 7.5-20.0 4.4 11.0 6.6-17.6
Rectum & rectosigmoid 8.4 13.9 9.9-19.0 5.6 19.2 12.6-28.3 2.8 9.6 5.1-16.6 1.4 2.3 0.9-4.9 0.8 3.0 0.8-7.8 0.6 1.9 0.4-5.9
Liver / intrahepatic bile duct 3.2 3.9 2.2-6.7 1.8 4.6 2.1-9.4 1.4 3.5 1.4-7.8 2.2 2.8 1.4-5.3 1.0 2.8 0.9-7.2 1.2 2.9 1.0-7.2
Pancreas 11.4 16.7 12.6-21.9 5.6 18.9 12.5-27.7 5.8 15.9 10.5-23.4 8.4 12.5 9.0-17.2 4.6 16.0 10.0-24.3 3.8 9.9 5.9-16.1
Larynx 1.6 2.3 1.0-4.8 1.2 3.8 1.4-8.7 0.4 0.9 0.1-4.4 1.2 1.7 0.6-3.9 0.8 2.6 0.7-7.1 0.4 0.8 0.1-4.1
Lung and bronchus 51.8 75.8 66.6-86.0 26.8 87.2 72.7-103.9 25.0 68.3 56.5-82.2 31.8 44.8 37.9-52.6 17.6 55.7 44.4-69.2 14.2 37.4 29.0-47.7
Melanoma of the skin 11.2 18.8 14.0-24.9 5.4 17.9 11.5-26.7 5.8 20.0 13.1-29.4 2.0 3.6 1.6-6.8 1.4 5.5 2.1-11.7 0.6 2.1 0.4-6.4
Female breast             41.0 117.6 101.5-135.7             5.4 14.8 9.5-22.4
Cervix uteri             1.8 6.7 2.9-13.0             1.0 3.2 1.0-8.0
Corpus uterus and NOS             10.6 29.6 21.9-39.4             2.0 4.6 2.1-9.3
Ovary             3.6 11.5 6.6-18.8             2.4 6.6 3.3-12.1
Prostate       28.4 89.4 74.9-106.2             6.6 22.3 15.2-31.8      
Testis       1.4 5.7 2.2-12.0             0.0 0.0 0.0-3.1      
Urinary bladder (incl. in situ) 22.2 32.2 26.4-39.2 15.8 52.7 41.4-66.2 6.4 16.2 10.8-23.5 4.2 5.6 3.4-8.9 3.2 10.3 5.8-17.1 1.0 2.4 0.7-6.5
Kidney and renal pelvis 12.8 21.0 15.9-27.1 7.6 26.9 18.8-37.4 5.2 16.1 10.2-24.3 2.0 2.7 1.3-5.2 1.2 3.6 1.3-8.5 0.8 2.1 0.6-6.0
Brain and other central nervous system 3.4 6.1 3.4-10.0 2.2 7.9 3.8-14.6 1.2 4.6 1.6-10.1 2.0 3.9 1.8-7.3 1.2 5.0 1.7-11.0 0.8 2.9 0.7-7.9
Thyroid 9.0 16.0 11.5-21.7 2.2 8.3 3.9-15.2 6.8 23.9 16.2-33.9 0.6 0.9 0.2-2.9 0.2 0.9 0.0-4.9 0.4 1.0 0.1-4.4
Hodgkin lymphoma 1.4 2.8 1.1-5.8 0.6 2.7 0.5-7.7 0.8 2.9 0.7-7.7 0.4 0.7 0.1-2.7 0.2 0.9 0.0-4.9 0.2 0.5 0.0-3.7
Non-Hodgkin lymphomas 12.4 20.0 15.2-26.0 5.8 20.9 13.7-30.4 6.6 19.5 13.2-27.9 2.8 4.0 2.1-7.1 1.2 4.3 1.5-9.6 1.6 3.5 1.5-7.8
Myeloma 4.4 6.6 4.1-10.3 1.8 7.1 3.2-13.6 2.6 6.7 3.5-12.1 2.2 3.3 1.6-6.1 1.0 3.4 1.0-8.3 1.2 3.0 1.1-7.2
Leukemias 16.6 26.1 20.6-32.8 10.4 37.3 27.5-49.5 6.2 15.2 10.1-22.3 4.8 6.8 4.3-10.5 1.8 6.5 2.9-12.8 3.0 6.8 3.7-12.1

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.